Supplement to "Effect and Safety of Hydroxysafflor Yellow A for Injection in Patients with Acute Ischemic Stroke of Blood Stasis Syndrome: A Phase II, Multicenter, Randomized, Double-Blind, Multiple-Dose, Active-Controlled Clinical Trial"

Chin J Integr Med. 2024 May 16. doi: 10.1007/s11655-024-3911-5. Online ahead of print.

Zi-Yi Zhou^{1

2

3

4}, Xia Wang⁵, Shan-Ye Gu², Ye-Feng Cai^{6

7

8

9}

¹ Department of Neurology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
² The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
³ Guangdong Provincial Key Laboratory of Research on Emergency in Traditional Chinese Medicine, Guangzhou, 510120, China.
⁴ Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, 510120, China.
⁵ Youcare Pharmaceutical Group Dingcheng Branch, Beijing, 100176, China.
⁶ Department of Neurology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China. caiyefeng@126.com.
⁷ The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China. caiyefeng@126.com.
⁸ Guangdong Provincial Key Laboratory of Research on Emergency in Traditional Chinese Medicine, Guangzhou, 510120, China. caiyefeng@126.com.
⁹ Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, 510120, China. caiyefeng@126.com.

No abstract available

Publication types